Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery (ANG-First Trial)

NCT06487585 is registered in ClinicalTrials.gov with University of Maryland St. Joseph Medical Center as lead sponsor.

NCT NCT06487585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06487585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery (ANG-First Trial)
Lead sponsor
University of Maryland St. Joseph Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
May 6, 2025
Completion date
February 28, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vasodilatory hypotension during or after cardiac surgery